These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11434385)

  • 81. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension.
    Tiede SL; Wassenberg M; Christ K; Schermuly RT; Seeger W; Grimminger F; Ghofrani HA; Gall H
    Int J Cardiol; 2016 Nov; 223():821-826. PubMed ID: 27575785
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Altered circulating levels of matrix metalloproteinases and inhibitors associated with elevated type 2 cytokines in lymphatic filarial disease.
    Anuradha R; George JP; Pavankumar N; Kumaraswami V; Nutman TB; Babu S
    PLoS Negl Trop Dis; 2012; 6(6):e1681. PubMed ID: 22679524
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study.
    Di Stefano V; Tubiolo C; Gagliardo A; Presti RL; Montana M; Todisco M; Lupica A; Caimi G; Tassorelli C; Fierro B; Brighina F; Cosentino G
    Brain Sci; 2022 Oct; 12(11):. PubMed ID: 36358365
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inflammation increases MMP levels via PGE
    Ozen G; Boumiza S; Deschildre C; Topal G; Longrois D; Jakobsson PJ; Michel JB; Jacob MP; Chahed K; Norel X
    Int J Obes (Lond); 2019 Sep; 43(9):1724-1734. PubMed ID: 30349011
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Association between MMP/TIMP Levels in the Aqueous Humor and Plasma with Axial Lengths in Myopia Patients.
    Yue Y; Hsiao YW; Zhou JB
    Biomed Res Int; 2020; 2020():2961742. PubMed ID: 32596291
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Circulating matrix metalloproteinases and their tissue inhibitors as markers for ethnic variation in pelvic floor tissue integrity.
    Rizk DEE; Al-Kafaji G; Jaradat AA; Al-Tayab D; Bakhiet M; Salvatore S
    Biomed Rep; 2018 Sep; 9(3):233-240. PubMed ID: 30271599
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study.
    Kuliczkowski W; Banaszkiewicz M; Mysiak A; Makaś G; Bil-Lula I
    Cardiol Res Pract; 2019; 2019():6921315. PubMed ID: 31781384
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases.
    Dorsch MF; Barrett JA; Lawrance RA; Maqbool A; Durham NP; Ellis S; Samani NJ; Bishop T; Ball SG; Balmforth AJ; Hall AS
    J Hum Genet; 2003; 48(10):508-513. PubMed ID: 14505232
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A combined biomarker approach for characterising extracellular matrix profiles in acute myocardial infarction.
    Brunton-O'Sullivan MM; Holley AS; Hally KE; Kristono GA; Harding SA; Larsen PD
    Sci Rep; 2021 Jun; 11(1):12705. PubMed ID: 34135421
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sex-specific Association of Matrix Metalloproteinases with Secondary Injury and Outcomes after Intracerebral Hemorrhage.
    Howe MD; Furr JW; Zhu L; Edwards NJ; McCullough LD; Gonzales NR
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1718-1725. PubMed ID: 30922669
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reduced levels of potential circulating biomarkers of cardiovascular diseases in apparently healthy vegetarian men.
    Navarro JA; de Gouveia LA; Rocha-Penha L; Cinegaglia N; Belo V; Castro MM; Sandrim VC
    Clin Chim Acta; 2016 Oct; 461():110-3. PubMed ID: 27496081
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 Jun; 13(5):691-2. PubMed ID: 17615626
    [No Abstract]   [Full Text] [Related]  

  • 93. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.
    Tayebjee MH; Lip GY; MacFadyen RJ
    Curr Med Chem; 2005; 12(8):917-25. PubMed ID: 15853705
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD.
    Polonskaya YV; Kashtanova EV; Murashov IS; Striukova EV; Kurguzov AV; Stakhneva EM; Shramko VS; Maslatsov NA; Chernyavsky AM; Ragino YI
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34205079
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MMP-9, Vertebrobasilar Ectasia and Vertebral Artery Dominance in Vertigo or Dizziness Patients With Vascular Risk Factors.
    Zhang HL; Peng YF; Zhang DP; Li D; Liu FX; Zhao M; Yin S; Liang JX; Wei TT
    Front Neurol; 2020; 11():931. PubMed ID: 32982940
    [No Abstract]   [Full Text] [Related]  

  • 96. Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.
    Jonsson A; Hjalmarsson C; Falk P; Ivarsson ML
    Br J Cancer; 2016 Sep; 115(6):703-6. PubMed ID: 27187685
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Contribution of circulating biomarkers to unravel the role of extracellular matrix in hypertensive cardiac remodelling.
    Beaumont J; González A; López B; Ravassa S; Díez J
    J Hypertens; 2012 Jan; 30(1):34-7. PubMed ID: 22157583
    [No Abstract]   [Full Text] [Related]  

  • 98. Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study.
    Tengiz I; Ercan E; Aliyev E; Sekuri C; Duman C; Altuglu I
    Curr Control Trials Cardiovasc Med; 2004 Oct; 5(1):10. PubMed ID: 15482602
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications.
    Zucker S; Doshi K; Cao J
    Adv Clin Chem; 2004; 38():37-85. PubMed ID: 15521188
    [No Abstract]   [Full Text] [Related]  

  • 100. Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study.
    Błaszczyk E; Lorek M; Francuz T; Gieburowska J; Gawlik A
    Int J Endocrinol; 2018; 2018():9715790. PubMed ID: 30245717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.